Otsuka Pharmaceutical Co., Ltd.
Clinical trials sponsored by Otsuka Pharmaceutical Co., Ltd., explained in plain language.
Pharmaceutical company developing treatments for mental health and other diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Migraine drug AJOVY under Real-World safety spotlight Results expected Sep 2026 (estimated)
- New eczema foam shows promise in Late-Stage trial Results expected Dec 2026 (estimated)
- New eczema foam shows promise for kids in Late-Stage trial Results expected Feb 2027 (estimated)
- New ADHD pill tested for Year-Long safety in kids Results expected Aug 2027 (estimated)
- New daily pill for kids with ADHD enters key trial Results expected Aug 2027 (estimated)
-
Heart failure drug samtasu put to the test in 1,600-Patient safety survey
Disease control OngoingThis study monitors the safety of the intravenous drug Samtasu (tolvaptan sodium phosphate) in people with heart failure who have fluid overload. Researchers will track side effects, including serious events and off-label use, in about 1,600 patients. The goal is to confirm the d…
Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Japanese study monitors safety of samsca for SIADH patients
Disease control OngoingThis study tracks the safety of the drug Samsca (tolvaptan) in 300 Japanese patients with low sodium levels caused by SIADH. Researchers will record any side effects or special situations that occur during routine use. The goal is to confirm the drug's safety in real-world settin…
Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC